Raymond James Financial Services Advisors Inc. raised its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) by 23.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,733 shares of the company's stock after buying an additional 2,004 shares during the period. Raymond James Financial Services Advisors Inc.'s holdings in Doximity were worth $324,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of DOCS. Bank of New York Mellon Corp raised its holdings in Doximity by 60.6% during the first quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company's stock valued at $9,004,000 after buying an additional 65,196 shares in the last quarter. US Bancorp DE raised its holdings in Doximity by 325.4% during the first quarter. US Bancorp DE now owns 2,646 shares of the company's stock valued at $138,000 after buying an additional 2,024 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its holdings in Doximity by 417.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company's stock valued at $1,099,000 after buying an additional 17,021 shares in the last quarter. Natixis Advisors L.P. bought a new position in Doximity during the first quarter valued at about $983,000. Finally, BlackRock Inc. raised its holdings in Doximity by 53.6% during the first quarter. BlackRock Inc. now owns 2,052,183 shares of the company's stock valued at $106,898,000 after buying an additional 716,547 shares in the last quarter. 52.48% of the stock is currently owned by institutional investors.
Get Doximity alerts:Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the company. Piper Sandler dropped their price objective on Doximity from $39.00 to $35.00 in a research note on Friday, November 11th. Wells Fargo & Company lifted their price objective on Doximity from $38.00 to $44.00 and gave the stock an "overweight" rating in a research note on Friday, November 11th. Evercore ISI lifted their price objective on Doximity from $28.00 to $32.00 in a research note on Friday, November 11th. Morgan Stanley lowered Doximity from an "equal weight" rating to an "underweight" rating and dropped their price objective for the stock from $32.00 to $29.00 in a research note on Friday, January 6th. Finally, BTIG Research assumed coverage on Doximity in a research note on Thursday, October 13th. They issued a "neutral" rating on the stock. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $41.40.
Doximity Trading Up 4.5 %
DOCS stock opened at $34.95 on Friday. Doximity, Inc. has a 1-year low of $22.91 and a 1-year high of $64.95. The firm has a market cap of $6.73 billion, a P/E ratio of 53.77, a P/E/G ratio of 17.21 and a beta of 0.86. The business's 50 day moving average is $33.46 and its 200-day moving average is $33.20.Doximity (NASDAQ:DOCS – Get Rating) last released its quarterly earnings data on Thursday, November 10th. The company reported $0.12 earnings per share for the quarter, meeting the consensus estimate of $0.12. Doximity had a return on equity of 16.41% and a net margin of 36.70%. The company had revenue of $102.19 million for the quarter, compared to analyst estimates of $99.86 million. Sell-side analysts forecast that Doximity, Inc. will post 0.52 EPS for the current year.
Doximity Profile
(Get Rating)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Get Rating).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.